Biomarin International Limited NDCs and Package Codes
This page lists NDC package records associated with labeler code 71931 (Biomarin International Limited) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
2
Package NDCs
2
Products
2
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 2 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| cerliponase alfa 150 mg/5mL INJECTION, SOLUTION | 71931-0820-99 | — | On market | View → |
| elosulfase alfa 5 mg/5mL INJECTION, SOLUTION, CONCENTRATE | 71931-0500-99 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.